secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zai Lab Ltd (ZLAB)
CIK:        0001704292
Form:       8-K
Filed at:   2022-05-10T23:59:59+00:00
Accession:  0001193125-22-146289
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zai Lab Q1 2022 results; excerpts lack financials; auditor, share split, COO announced
--------------------------------------------------------------------------------

- Announced Q1 2022 financial results on May 10, 2022; specific revenue and earnings figures not visible in the provided excerpt.
- Engaged KPMG as independent auditor for FY2022, replacing prior auditor, to comply with PCAOB inspection and Nasdaq listing requirements.
- Shareholders approved 1-for-10 ordinary share subdivision effective March 30, 2022, aimed at increasing liquidity and lowering trading price.
- Appointed Josh Smiley as COO effective August 2022; he brings over 26 years of biopharmaceutical industry experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704292/000119312522146289/0001193125-22-146289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704292/000119312522146289/d315602d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-146289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer